Healius Raised to Neutral From Underweight by JPMorgan >HLS.AU
Healius Downgraded to Underweight From Neutral by Barrenjoey
Wall Street Analysts Are Bullish on Top Healthcare Picks
Jarden Research Adjusts Healius' Price Target to AU$1.22 From AU$1.26, Keeps at Underweight
Morgan Stanley Adjusts Healius' Price Target to AU$1 From AU$1.30, Keeps at Underweight
No Data
No Data